Promontory Therapeutics Expands Clinical Trial for Prostate Cancer Treatment
By Daniella Parra Promontory Therapeutics, a clinical stage pharmaceutical company focused on oncology, said it...
By Daniella Parra Promontory Therapeutics, a clinical stage pharmaceutical company focused on oncology, said it...
Join ICR for a retail industry outlook on Thursday, July 27, 2023 from 12 PM...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA), announced the successful completion of a private...
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) announced positive Phase 1 clinical trial results for...
By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) said it plans to conduct a clinical trial...
By Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has appointed Richard...
By Daniella Parra Marti Technologies Inc. announced that its Class A Ordinary Shares and warrants...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) announced the appointment of Brant Binder, a seasoned leader...
By Daniella Parra On Holding AG (NYSE: ONON) said it is opening a new store...
By Daniella Parra A recent survey by ProSomnus, Inc. (NASDAQ: OSA) and Proedge revealed that...